Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Plant-derived Quadrivalent VLP Influenza Vaccine in Elderly Adults
NCT03739112Phase 3Completed
- Sponsor
- Medicago Inc.
- Start
- Sep 2018
- Primary completion
- May 2019
- Countries
- 5
01
Overview
Phase 3, randomised, single-blind trial in influenza (2 arms), sponsored by Medicago Inc. Primary endpoint: Number of Occurrences of Protocol-Defined Influenza-Like Illness Due to Any Laboratory-Confirmed Influenza Strains. Started Sep 2018; status: completed.
02
Conditions
influenza
Beyond the preview
Go deeper on NCT03739112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03739112.